Your browser doesn't support javascript.
loading
Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial.
Cochran, Gerald; Shen, Jincheng; Cox, Nicholas; Field, Craig; Carlston, Kristi; Sengpraseut, Britnee; White, Ashley; Okifuji, Akiko; Jackman, Carina; Haaland, Benjamin; Ragsdale, Russ; Gordon, Adam J; Tarter, Ralph.
Afiliación
  • Cochran G; University of Utah, Department of Internal Medicine, 30 N 1900 E, Room 4C104, Salt Lake City, UT 84132, USA. Electronic address: jerry.cochran@hsc.utah.edu.
  • Shen J; University of Utah, Department of Internal Medicine, 30 N 1900 E, Room 4C104, Salt Lake City, UT 84132, USA. Electronic address: jincheng.shen@hsc.utah.edu.
  • Cox N; University of Utah, College of Pharmacy, 30 2000 E, Salt Lake City, UT 84112, USA. Electronic address: nicholas.cox@pharm.utah.edu.
  • Field C; University of Texas, El Paso, Department of Psychology, 500 W University, El Paso, TX 79902, USA. Electronic address: cfield@utep.edu.
  • Carlston K; University of Utah, Department of Internal Medicine, 30 N 1900 E, Room 4C104, Salt Lake City, UT 84132, USA. Electronic address: kristi.carlston@hsc.utah.edu.
  • Sengpraseut B; University of Utah, Department of Internal Medicine, 30 N 1900 E, Room 4C104, Salt Lake City, UT 84132, USA. Electronic address: britnee.sengpraseut@hsc.utah.edu.
  • White A; University of Utah, Department of Internal Medicine, 30 N 1900 E, Room 4C104, Salt Lake City, UT 84132, USA. Electronic address: ashley.white@hsc.utah.edu.
  • Okifuji A; University of Utah, Department of Anesthesiology, 30 N 1900 E, RM 3C444 SOM, Salt Lake City, UT 84132, USA. Electronic address: akiko.okifuji@hsc.utah.edu.
  • Jackman C; University of Utah, Department of Anesthesiology, 30 N 1900 E, RM 3C444 SOM, Salt Lake City, UT 84132, USA. Electronic address: carina.jackman@hsc.utah.edu.
  • Haaland B; University of Utah, Department of Population Health Sciences, 295 Chipeta Way, Williams Building, Room 1N410, Salt Lake City, UT 84108, United States of America. Electronic address: benjamin.haaland@hci.utah.edu.
  • Ragsdale R; University of Utah Health, Pharmacy Administration, 127 500 E #160, Salt Lake City, UT 84102, USA. Electronic address: russell.ragsdale@hsc.utah.edu.
  • Gordon AJ; University of Utah, Department of Internal Medicine, 30 N 1900 E, Room 4C104, Salt Lake City, UT 84132, USA. Electronic address: adam.gordon@hsc.utah.edu.
  • Tarter R; University of Pittsburgh, School of Pharmacy, 3501 Terrace St, Pittsburgh, PA 15261, USA. Electronic address: tarter@pitt.edu.
Contemp Clin Trials ; 116: 106759, 2022 05.
Article en En | MEDLINE | ID: mdl-35417771
BACKGROUND: >1 in 3 of the 9 million individuals engaged in opioid medication misuse obtain legitimate opioid prescriptions and fill these in community pharmacies, which are subsequently misused. This study is testing the efficacy of a pharmacist-led intervention-Brief Intervention-Medication Therapy Management (BI-MTM)-compared to standard medication counseling (SMC) to address opioid medication misuse. METHODS: Design. This study is a single-blinded 2-group parallel randomized trial within 13 community pharmacies that will enroll 350 individuals. Participant Recruitment. Pharmacy staff approach patients and ask about interest in completing a brief confidential screening tool, which includes opioid medication misuse assessment. Interested patients who report misuse are asked to provide informed consent. Enrolled patients are assessed for behavioral and physical health at enrollment, 2-months post-enrollment, and 6-months post-enrollment. INTERVENTIONS: Following baseline assessment, participants are randomized (1:1 ratio) to: SMC, a medication information/counseling intervention or BI-MTM, an intervention comprised by 4 evidence-based components: medication therapy management, brief intervention, naloxone dispensing, and patient navigation. ANALYSES: Primary analyses involve estimating 3-level generalized linear mixed models to relate repeated assessments across time of opioid medication misuse (i.e., the Prescription Opioid Misuse Index) to the intervention. CONCLUSION: Study results will provide the first critical step towards integrating a highly accessible, low-cost approach to managing risks related to opioid use. Community pharmacies provide an incredibly important setting in which patients can receive high quality care to support health behavior change. Successfully completing this project sets the stage for a large-scale effectiveness study. (NCT#: NCT05141266).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacias / Mal Uso de Medicamentos de Venta con Receta / Trastornos Relacionados con Opioides Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacias / Mal Uso de Medicamentos de Venta con Receta / Trastornos Relacionados con Opioides Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos